Navigation Links
Reportlinker Adds Advances in Biopharmaceutical Technology in China
Date:8/25/2010

NEW YORK, Aug. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Advances in Biopharmaceutical Technology in China

http://www.reportlinker.com/p0265200/Advances-in-Biopharmaceutical-Technology-in-China.html

Every organization has a China strategy, though for many of us it is simply "ignore it." A great opportunity exists in working with China and implementing an effective company strategy. However, winning in Asia in the new millennium will require fundamental changes in partnerships between western and Asian companies. Every company faces the question "What should our China strategy be?" But to neglect China is to forego opportunities to gain efficiency in most of the things we are trying to do. China provides opportunities that allow us to do different things and not just do things differently.

This volume provides an overview of the biopharmaceutical industry, and the state of technology. It will help the reader understand general business practice in China, analyze business opportunities and in identifying potential partners for working in China. It provides a ready reference for all aspects of the world of biopharmaceuticals in China, including general understanding, detailed technical and business descriptions, and detailed information on all types of organizations involved in biopharmaceuticals in China, whether they be companies (state owned or privately owned), universities, or government institutions.

By the Numbers:-46 Internationally Recognized Authors

-23 Peer-Reviewed Chapters

-900 Pages

-15 Translated Chapters and Case Studies

-19 Case Studies and China Briefs

-380 References

-Over 2,000 Index Entries

-Current Listing of over 2,000 Chinese Biopharmaceuticals and Diagnostics (database)

Abstracts Chapter 1: Introduction: A China Biopharmaceuticals Strategy

Chapter 2: An Overview of Biopharmaceutical Developments in China

Chapter 3: China's Healthcare System and the Demand for Biopharmaceutical Products

Chapter 4: China Pharmaceuticals Market Situation 2006

Chapter 5: Biopharmaceutical Strategy in China: An Analysis of Innovation, Financing Policies, Talent, and Strategic Considerations Through 2010 (11th 5-year Plan)

Chapter 6: Biopharmaceuticals in China: A Market, Import/Export, and Financial Review

Chapter 7: Pharmacy and Drug Administration in China

Chapter 8: Regulatory Requirements Applicable to Clinical Trials in China

Chapter 9: FDA Requirements Applicable to Testing and Manufacturing Pharmaceutical Products in China for the U. S. Market

Chapter 10: Protection and Enforcement of Biopharmaceutical Intellectual Property Rights in China - A Rapidly Evolving System

Chapter 11: Biopharmaceutical Industry Venture Capital Investment in Mainland China

Chapter 12: Drug Discovery and Development Partnerships: Outsourcing and Partnering with China

Chapter 13: Doing Business in China

Chapter 14: Current Status and Future Prospect of Biogeneric Companies in China

Chapter 15: Biopharmaceutical Products in China

Chapter 16: Chinese Bioindustry Parks: Evolution and Growth

Chapter 17: Organizations in China involved in Biopharmaceutical Research and Manufacturing

Chapter 18: Life Science and Health Science Education in China

Chapter 19: Biopharmaceutical Research Collaboration between Western and Chinese Life Science Organization: A Guide to Prospective Partnership

Chapter 20: Industrial Technology Developments for Chinese Biopharmaceuticals

Chapter 21: Therapeutic Proteins in China

Chapter 22: Vaccines in China: Status of the Chinese Vaccine Industry

Chapter 23: Biotechnology and Analytical Methods in the Modernization of Traditional Chinese Herbal Medicine

Chapter 24: CHINA Briefs (Miscellaneous Articles)

Author Organizations:

Arnold & Porter, LLP

Beijing BaiAo Pharmaceutical Co., Ltd.

Beijing WanTai Biological Product Co., Ltd.

Business Monitor International

CanBiotech

Chemical Industry Press (China)

Chiltern International

China National Center for Biotechnology Development

China National Development and Reform Commission, Chinese Academy of Macroeconomic Research

China National Development and Reform Commission, High-Tech Industry Department

China Pharmaceutical University, College of Life Science and Technology

Chinese Academy of Social Sciences (CASS), Institute of World Economics and Politics

Chinese Ministry of Science and Technology, National Advisory Committee for "863 High Technology Program"

Deacons Hong Kong

Fudan University, International Finance

MMD Pharmahe

Nanjing University, Department of Biochemistry

National Institutes of Health (NIH), Office of Technology Transfer

National Vaccine & Serum Institute

Perkins Coie LLP (Los Angeles)

Shandong University

Shanghai CITIC GuoJian Pharmaceutical Co., Ltd.

Shanghai Tongji University, Investment Research Institute

Shanghai Venture Capital Corporation

Shenzhen Neptunus Interlong Biotech Co., Ltd

Shenzhen ZYPH Intelligence Co., Ltd.

Sichuan University, West China School of Pharmacy

Strategic Manufacturing Worldwide, Inc.

TechNova Medical Services

Tsinghua University, School of Medicine

3DBGlobal, Inc.

To order this report:Biopharmaceutical Industry: Advances in Biopharmaceutical Technology in China

Biopharmaceutical Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Contact Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... 2016  Regular discussions on a range of subjects including ... two entities said Poloz. Speaking at a lecture ... , he pointed to the country,s inflation target, which is ... "In certain areas there ... common economic goals, why not sit down and address strategy ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
Breaking Biology Technology:
(Date:6/22/2016)... June 22, 2016   Acuant , ... verification solutions, has partnered with RightCrowd ® ... for Visitor Management, Self-Service Kiosks and Continuous ... that add functional enhancements to existing physical ... and venues with an automated ID verification ...
(Date:6/21/2016)... British Columbia , June 21, 2016 /PRNewswire/ ... appointed to the new role of principal product ... been named the director of customer development. Both ... NuData,s chief technical officer. The moves reflect NuData,s ... teams in response to high customer demand and ...
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
Breaking Biology News(10 mins):